Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment

Pituitary metastasis from renal cell carcinoma is rare and has never been reported for renal cell carcinoma primarily treated with sorafenib. Herein, we present a case of an advanced clear-cell renal cell carcinoma in which pituitary metastasis progressed but extracerebral metastases showed partial...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lin, Yu, Shi-Ying, Hu, Guang-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sun Yat-sen University Cancer Center 2013
Materias:
Case Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845622/
https://www.ncbi.nlm.nih.gov/pubmed/23237217
http://dx.doi.org/10.5732/cjc.012.10184
_version_ 1782293339115094016
author Yang, Lin
Yu, Shi-Ying
Hu, Guang-Yuan
author_facet Yang, Lin
Yu, Shi-Ying
Hu, Guang-Yuan
author_sort Yang, Lin
collection PubMed
description Pituitary metastasis from renal cell carcinoma is rare and has never been reported for renal cell carcinoma primarily treated with sorafenib. Herein, we present a case of an advanced clear-cell renal cell carcinoma in which pituitary metastasis progressed but extracerebral metastases showed partial response to sorafenib treatment.
format Online
Article
Text
id pubmed-3845622
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Sun Yat-sen University Cancer Center
record_format MEDLINE/PubMed
spelling pubmed-38456222013-12-11 Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment Yang, Lin Yu, Shi-Ying Hu, Guang-Yuan Chin J Cancer Case Research Pituitary metastasis from renal cell carcinoma is rare and has never been reported for renal cell carcinoma primarily treated with sorafenib. Herein, we present a case of an advanced clear-cell renal cell carcinoma in which pituitary metastasis progressed but extracerebral metastases showed partial response to sorafenib treatment. Sun Yat-sen University Cancer Center 2013-06 /pmc/articles/PMC3845622/ /pubmed/23237217 http://dx.doi.org/10.5732/cjc.012.10184 Text en Chinese Journal of Cancer http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License, which allows readers to alter, transform, or build upon the article and then distribute the resulting work under the same or similar license to this one. The work must be attributed back to the original author and commercial use is not permitted without specific permission.
spellingShingle Case Research
Yang, Lin
Yu, Shi-Ying
Hu, Guang-Yuan
Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment
title Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment
title_full Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment
title_fullStr Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment
title_full_unstemmed Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment
title_short Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment
title_sort pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment
topic Case Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845622/
https://www.ncbi.nlm.nih.gov/pubmed/23237217
http://dx.doi.org/10.5732/cjc.012.10184
work_keys_str_mv AT yanglin pituitarymetastasisfromarenalcellcarcinomaprogressedaftersorafenibtreatment
AT yushiying pituitarymetastasisfromarenalcellcarcinomaprogressedaftersorafenibtreatment
AT huguangyuan pituitarymetastasisfromarenalcellcarcinomaprogressedaftersorafenibtreatment

Ejemplares similares